For the therapy of AD, antidiabetic peptides, such as insulin and GLP-1 receptor agonist, have been tested for their potential in promoting memory and learning functions by facilitating the insulin receptor signaling and glucose transport in hippocampal neurons (Kamei et al., 2018). The gene discussed is INSR; the disease is Alzheimer disease.